Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
European Journal of Pharmacology|April 10, 2012
Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potentialDimitry A Chistiakov, Vladimir P ChekhoninVirus Research|August 21, 2018
Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIXAleksei A Stepanenko, Vladimir P ChekhoninTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 28, 2014
Extracellular vesicles shed by glioma cells: pathogenic role and clinical valueDimitry A Chistiakov, Vladimir P ChekhoninGene|September 2, 2018
A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapyAleksei A Stepanenko, Vladimir P ChekhoninThe World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 27, 2017
Early-life adversity-induced long-term epigenetic programming associated with early onset of chronic physical aggression: Studies in humans and animalsDimitry A Chistiakov, Vladimir P ChekhoninBiomedicines|December 1, 2019
On the Critical Issues in Temozolomide Research in Glioblastoma: Clinically Relevant Concentrations and MGMT-independent ResistanceAleksei A Stepanenko, Vladimir P ChekhoninCancers|December 20, 2018
Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?Aleksei A Stepanenko, Vladimir P ChekhoninExperimental and Molecular Pathology|July 21, 2018
Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiformeDimitry A Chistiakov, Vladimir P ChekhoninCurrent Pharmaceutical Design|November 1, 2017
Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent ModelsDimitry A Chistiakov, Yuri V Bobryshev, Vladimir P ChekhoninEuropean Journal of Pharmacology|June 7, 2017
The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiformeDimitry A Chistiakov, Ivan V Chekhonin, Vladimir P ChekhoninPageof 11